Barium Mining News in British Columbia

Voyageur Pharmaceuticals Ltd.
Voyageur Pharmaceuticals Ltd.
VM
British Columbia

Voyageur Pharmaceuticals Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial with Alberta Innovates Grant; Announces Stock Option and DSU grants, and Proposed Issuance of Securities for Debt

Voyageur Pharmaceuticals has confirmed that its Frances Creek barite meets pharmaceutical-grade purity standards, with an average BaSO4 assay of 98.8%. The company is progressing toward Health Canada human trials and has secured non-dilutive funding through the Alberta Innovates program.

View story
Voyageur Pharmaceuticals Ltd.
Voyageur Pharmaceuticals Ltd.
VM
Barium
British Columbia

Voyageur Pharmaceuticals Initiates First Commercial Shipments of Barium Contrast Products to Canadian Clinics

Voyageur Pharmaceuticals has commenced its first commercial shipments of Health Canada-approved barium contrast products to Canadian clinics. The company also highlighted its Frances Creek Project in British Columbia, which contains a 121,000-tonne indicated and inferred barium sulfate resource.

View story
Voyageur Pharmaceuticals Ltd.
Voyageur Pharmaceuticals Ltd.
VM
British Columbia

Voyageur Enters Revenue Stage with First Commercial Sale of Barium Contrast Agents

Voyageur Pharmaceuticals has announced its first commercial sale of barium contrast agents, totaling C$89,000. The company also highlighted its 120,000-tonne Frances Creek barium sulfate resource in British Columbia, valued at C$344M.

View story